Innovator Series: Aurinia Pharmaceuticals, Inc.

Melinda Starling
By Robert Huizinga, Ph.D., R.N., CNeph©, Executive Vice President, Corporate Development and Neil Solomons, MD, Chief Medical Officer at Aurinia Pharmaceuticals1. Tell us about your first experience with a kidney patient, personal or professional, and what impressions that left on you as a fellow human being. RH:
Read More

How Are We Going to Open Up Safely?

Melinda Starling
By Stephen Z. Fadem, MD, FASN, Chairman, Medical Advisory Board AAKPIntroduction The COVID-19 pandemic has taken the world by surrise and been costly in terms of life. As of May 27, 2020, there were over 100,000 deaths related to COVID-19 in the United States. By June 8, another 11,700 had died (Source: https://coronavirus.jhu.edu/map.html)
Read More

AST, ASTS & AAKP Request Swift Passage of S. 3353, the Comprehensive Drug Coverage for Kidney Transplant Patients Act, During the 116th Congress

Jennifer Duplessie
July 17, 2020 The Honorable Mitch McConnellMajority LeaderUnited States Senate The Honorable Charles Grassley ChairmanFinance CommitteeUnited States Senate The Honorable Charles SchumerMinority LeaderUnited States Senate The Honorable Ron WydenRanking MemberFinance CommitteeUnited States Senate RE:
Read More